StockData
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. (NAGE) stock

NAGENasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3011% below fair value
$1.94−0.10 (-4.90%)

Close on Nov 18, 2026Market cap $153.50MP/E 16.2Yield –

Niagen Bioscience market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Niagen Bioscience's market cap was $165.31M on Nov 11, 2026, against $539.16M a year earlier. Over the last 5 years it ranged from $83.83M to $1.13B, with a median of $224.71M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$165.31M-67.4%
2025Dec 31, 2025$506.50M+25.6%
2024Dec 31, 2024$403.32M+276.5%
2023Dec 29, 2023$107.12M-6.5%
2022Dec 30, 2022$114.52M-55.0%
2021Dec 31, 2021$254.67M+86048.9%
2020Dec 31, 2020$295.62K+15.5%
2019Dec 31, 2019$255.94K+35.9%
2018Dec 31, 2018$188.37K-99.9%
2017Dec 29, 2017$280.18M+125.5%
2016Dec 30, 2016$124.27M-4.2%
2015Dec 31, 2015$129.67M+40.7%
2014Dec 31, 2014$92.15M-34.2%
2013Dec 31, 2013$140.05M+188.3%
2012Dec 31, 2012$48.57M+21.1%
2011Dec 30, 2011$40.12M–

More Niagen Bioscience figures

See a number that looks wrong?